Dr Caroline Rudisill is an associate professor in Health Economics at the London School of Economics. She is also a visiting senior research fellow in in the Health and Social Care Research Division, Faculty of Life Science and Medicine, King’s College London.
Caroline holds a PhD in Social Policy (concentration in Health Economics) from the LSE, MSc (with distinction) in International Health Policy (Health Economics) from the LSE and a BA (cum laude) in Economics from Georgetown University in Washington, DC. Prior to coming to the LSE originally for her MSc, Caroline worked for Goldman Sachs in New York City and at Analysis Group in Washington, DC, an economic consultancy. She has also worked at McKinsey in London serving public and private sector health care clients.
Caroline has also worked on pharmaceutical and health economics issues for various consultancies, pharmaceutical companies and international organizations. She is currently a member of the World Health Organization (WHO) guideline development group for building National Capacities to communicate risks during public health emergencies.
Caroline's research interests focus on two main areas. First, she examines individual decision-making regarding health-related behaviors, in particular treatment choices and preventive behaviors that involve risk. She has conducted research on the use of demand-side financial incentives in preventive and primary care settings, risk perceptions about vaccines and behaviors in the face of public health risks such as smoking and avian flu.
Second, Caroline is interested in the use of economic evaluation to play a role in coverage decisions in health systems worldwide. This research includes modelling treatment choices and examining the policy implications of economic evaluation results. For example, she has recently been involved in economic evaluations of bariatric surgery and automated image screening for diabetic retinopathy.and plans to continue work in the areas of diabetes and obesity-related interventions. Her interests are in both prevention and treatment of these health issues.
Fildes, A., Charlton, J., Rudisill, C., Littlejohns, P., Prevost, T., and Gulliford M.C. (2015). What is the probability of an obese person attaining normal body weight? Cohort study using electronic health records, American Journal of Public Health, doi: 10.2105/AJPH.2015.302773.
Dolan, P. and C. Rudisill*. (2014). The effect of financial incentives on chlamydia testing rates: Evidence from a randomized experiment, Social Science & Medicine, 105:140-148.
Gulliford, M. Charlton, J., Bhattarai, N., Charlton, C. and C. Rudisill. Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care: Population-based cohort study and Markov model (2014). European Journal of Health Economics, 15(4): 341-351.
Rudisill, C*. (2013). How do we handle new health risks?: Optimism, risk perception and swine flu vaccination, Journal of Risk Research, 16(8): 959-980.
For a full list of Caroline's publications, please see her LSE Research Online Page.
Caroline has taught a variety of health economics and health policy courses to a number of student groups. She convenes two courses on economic evaluation – Cost Effectiveness Analysis in Health Care (full-time Msc students) and Resource Allocation and Cost-Effectiveness Analysis (executive Msc students). She also teaches on Health Economics for full-time Msc students and Health and Social Care Policy for undergraduates.